Conference Coverage

Heart disease in GPA exacts high toll in year 2 and beyond


 

REPORTING FROM RHEUMATOLOGY 2018

– Cardiovascular disease was the predominant cause of death of patients with granulomatosis with polyangiitis 1-5 years after a diagnosis in a study by U.K. researchers, suggesting that this could be a target for future intervention.

While active disease was the No. 1 cause of death within the first year of diagnosis in 40% of patients with granulomatosis with polyangiitis (GPA), it was overtaken by cardiovascular disease (CVD) as the main cause of death in 37.5% of patients in the next 4 years from diagnosis.

Dr. Fiona A. Pearce of the division of epidemiology and public health at the University of Nottingham, England. Sara Freeman/MDedge News

Dr. Fiona A. Pearce

Nevertheless, active disease remained an important cause of death, accounting for 10% of deaths at 1-5 years, 18.2% at 5-10 years, and 16.7% at 10-15 years.

“The idea for this study came from patients with vasculitis who were polled by Vasculitis UK,” Fiona A. Pearce, MBBS, explained at the British Society for Rheumatology annual conference.

“Further research into mortality was one of their top priorities as patients want to know the honest truth about what is going to happen to them,” added Dr. Pearce, of the division of epidemiology and public health at the University of Nottingham (England).

GPA is a rare type of vasculitis that is estimated to occur in around 1,350 people every year in the United Kingdom. Mortality is known to be high, with around 11%-14% of patients dying in the first year of diagnosis, but there are few data on what happens over a longer term.

The aim of the study was therefore to examine patient survival in the long term – what were the mortality rates several years post diagnosis? Did the risk of death remain high throughout this time and did the causes of death change?

Pages

Recommended Reading

TB in 2017: Good news and bad news
MDedge Internal Medicine
Few acutely ill hospitalized patients receive VTE prophylaxis
MDedge Internal Medicine
Dermatology practice gaps: improving medication management
MDedge Internal Medicine
SLE: Specialized lupus clinics may offer superior quality of care
MDedge Internal Medicine
Patient perspective improves dry eye syndrome research
MDedge Internal Medicine
Infections predispose patients to developing Sjögren’s
MDedge Internal Medicine
Self-administration of subcutaneous belimumab could eliminate hospital visits for SLE patients
MDedge Internal Medicine
Lupus is quietly killing young women
MDedge Internal Medicine
MDedge Daily News: Which nonopioids are ripe for abuse?
MDedge Internal Medicine
MDedge Daily News: Lupus is quietly killing young women
MDedge Internal Medicine